Free Trial

Alpha Tau Medical (DRTS) Competitors

Alpha Tau Medical logo
$3.05 +0.03 (+0.99%)
As of 02:55 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

DRTS vs. PLSE, BLFS, TNDM, MDXG, INMD, KMTS, IRMD, SIBN, BBNX, and EMBC

Should you be buying Alpha Tau Medical stock or one of its competitors? The main competitors of Alpha Tau Medical include Pulse Biosciences (PLSE), BioLife Solutions (BLFS), Tandem Diabetes Care (TNDM), MiMedx Group (MDXG), InMode (INMD), Kestra Medical Technologies (KMTS), iRadimed (IRMD), SiBone (SIBN), Beta Bionics (BBNX), and Embecta (EMBC). These companies are all part of the "medical equipment" industry.

Alpha Tau Medical vs. Its Competitors

Alpha Tau Medical (NASDAQ:DRTS) and Pulse Biosciences (NASDAQ:PLSE) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their valuation, earnings, analyst recommendations, institutional ownership, dividends, profitability, media sentiment and risk.

2.7% of Alpha Tau Medical shares are held by institutional investors. Comparatively, 76.9% of Pulse Biosciences shares are held by institutional investors. 39.5% of Alpha Tau Medical shares are held by insiders. Comparatively, 71.5% of Pulse Biosciences shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

In the previous week, Alpha Tau Medical and Alpha Tau Medical both had 1 articles in the media. Pulse Biosciences' average media sentiment score of 1.87 beat Alpha Tau Medical's score of 0.94 indicating that Pulse Biosciences is being referred to more favorably in the news media.

Company Overall Sentiment
Alpha Tau Medical Positive
Pulse Biosciences Very Positive

Alpha Tau Medical's return on equity of -49.48% beat Pulse Biosciences' return on equity.

Company Net Margins Return on Equity Return on Assets
Alpha Tau MedicalN/A -49.48% -36.69%
Pulse Biosciences N/A -68.44%-58.17%

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Alpha Tau MedicalN/AN/A-$31.75M-$0.46-6.63
Pulse BiosciencesN/AN/A-$53.58MN/AN/A

Alpha Tau Medical has a beta of 0.99, meaning that its share price is 1% less volatile than the S&P 500. Comparatively, Pulse Biosciences has a beta of 1.56, meaning that its share price is 56% more volatile than the S&P 500.

Alpha Tau Medical presently has a consensus target price of $8.00, indicating a potential upside of 162.30%. Pulse Biosciences has a consensus target price of $22.00, indicating a potential upside of 49.00%. Given Alpha Tau Medical's higher probable upside, equities analysts clearly believe Alpha Tau Medical is more favorable than Pulse Biosciences.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Alpha Tau Medical
0 Sell rating(s)
0 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
3.00
Pulse Biosciences
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00

Summary

Alpha Tau Medical beats Pulse Biosciences on 5 of the 9 factors compared between the two stocks.

Get Alpha Tau Medical News Delivered to You Automatically

Sign up to receive the latest news and ratings for DRTS and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding DRTS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

DRTS vs. The Competition

MetricAlpha Tau MedicalMED INSTRUMENTS IndustryMedical SectorNASDAQ Exchange
Market Cap$258.70M$6.98B$5.71B$9.51B
Dividend YieldN/A1.28%4.60%3.99%
P/E Ratio-6.6325.4128.0720.02
Price / SalesN/A46.77459.47103.02
Price / CashN/A20.6736.5558.97
Price / Book3.434.738.615.88
Net Income-$31.75M$176.14M$3.24B$258.50M
7 Day Performance0.33%2.59%3.83%2.03%
1 Month Performance2.18%3.25%10.40%12.52%
1 Year Performance43.53%7.18%34.13%19.07%

Alpha Tau Medical Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
DRTS
Alpha Tau Medical
2.8696 of 5 stars
$3.05
+1.0%
$8.00
+162.3%
+43.8%$258.70MN/A-6.6380Positive News
PLSE
Pulse Biosciences
3.9584 of 5 stars
$14.97
-0.9%
$22.00
+47.0%
-18.9%$1.02B$700K0.00140Positive News
BLFS
BioLife Solutions
2.2726 of 5 stars
$20.76
-0.3%
$31.17
+50.1%
-0.4%$996.41M$82.25M-71.58440News Coverage
Positive News
Analyst Forecast
TNDM
Tandem Diabetes Care
4.2498 of 5 stars
$14.63
-0.9%
$32.71
+123.6%
-63.7%$983.79M$940.20M-5.262,650Positive News
MDXG
MiMedx Group
3.4061 of 5 stars
$6.65
+3.6%
$11.50
+72.9%
-7.2%$948.25M$348.88M24.63870Positive News
Upcoming Earnings
INMD
InMode
3.779 of 5 stars
$13.96
+0.4%
$18.54
+32.8%
-17.9%$878.29M$394.82M8.85480Upcoming Earnings
KMTS
Kestra Medical Technologies
N/A$16.63
+4.6%
$27.33
+64.4%
N/A$816.44M$59.81M0.00300
IRMD
iRadimed
4.9269 of 5 stars
$56.19
-0.9%
$72.00
+28.1%
+18.0%$720.81M$75.15M36.25110Upcoming Earnings
SIBN
SiBone
4.0617 of 5 stars
$16.67
+0.3%
$22.50
+35.0%
+5.7%$708.25M$167.18M-26.05350News Coverage
BBNX
Beta Bionics
N/A$14.30
+5.2%
$23.44
+63.9%
N/A$589.21M$65.12M0.00294News Coverage
Lockup Expiration
EMBC
Embecta
4.6859 of 5 stars
$10.29
+5.2%
$19.00
+84.6%
-30.4%$571.57M$1.12B11.432,100

Related Companies and Tools


This page (NASDAQ:DRTS) was last updated on 7/25/2025 by MarketBeat.com Staff
From Our Partners